Novacare Recalls Glucosamine Capsules Due to Inadequate Allergen Labeling
Novacare, LLC is recalling 961 bottles of Glucosamine 750 mg capsules nationwide because the product has inadequate allergen labeling.
The agency’s classification
FDA (Food): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves inadequate allergen labeling, which falls under the rubric criteria for 'Allergen mislabeling on common allergens' or 'risk-of-harm products where injury has not yet been reported.'
Plain-English summary
Novacare, LLC is conducting a field action on 961 bottles of Glucosamine 750 mg 120 ct capsules. The recall is being issued due to inadequate allergen labeling on the product.
The affected product is distributed nationwide, with no foreign or VA/govt/military consignees. The specific lot numbers involved are 4102801, 2071918.2, 2061401, and 2032006. The product is a capsule dosage form intended to be taken as 1-2 capsules, 750 mg each, three times daily with meals.
Consumers should stop using the product and check their lot numbers against the list provided. The source text does not specify a particular return address or refund process, so consumers should contact the manufacturer or retailer for further instructions.
The recalled product
- Product
- Glucosamine 750 mg 120 ct, Capsule, Dosage: 12 capsules, 750 mg ea., three times daily with meals
- Manufacturer
- Novacare, LLC
- Category
- Food — Dietary Supplement
- Hazard
- Affected units
- 961
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #s: 4102801
- 2071918.2
- 2061401
- 2032006
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Novacare, LLC
See all →- CriticalFDA Recalls Thermo FX Supplement for Unapproved Salicylic Acid
FDA (Drugs) · 2016-06-15
- SevereFDA Recalls Fataway Ultimate Stack Supplement for Unapproved Salicylic Acid
FDA (Drugs) · 2016-06-15
- SevereFDA Recalls Black Widow 25 Ephedra Fat Burner for Unapproved Ingredient
FDA (Drugs) · 2016-06-15
- CriticalFDA Recalls Asia Black 25 Ephedra Extreme Fat Burner for Unapproved Ingredients
FDA (Drugs) · 2016-06-15
- SevereFDA Recalls MaxOut Body Fat Burner for Unapproved Salicylic Acid
FDA (Drugs) · 2016-06-15
Same hazard · allergen mislabeling
See all →- HighElegant Foods Golden Raisins Recalled for Undeclared Sulfites
FDA (Food) · 2026-09-23
- HighElegant Foods Coconut Flakes Recalled for Undeclared Sulfites
FDA (Food) · 2026-09-23
- HighRaw sirloin beef tips recalled due to misbranding and undeclared allergens
USDA FSIS · 2025-09-10
- LowRodex Forte dietary supplement recalled for undeclared food dyes
FDA (Food) · 2025-07-02
- HighGluten Free Vegan Peanut Butter Jam Cookie recalled for undeclared sesame
FDA (Food) · 2025-06-18
Similar recalls
- ModerateHealthmaxx Recalls MAX Glucosamine Tablets Due to Mislabeling
FDA (Food) · 2013-10-02
- LowNovartis Recalls Maalox Antacid Tablets Due to Illegible Packaging Labels
FDA (Drugs) · 2013-08-28
- HighNatural Creations Recalls Glucosamine MSM Supplement for Unlabeled Shellfish Allergen
FDA (Food) · 2015-07-01
- LowNovartis Recalls Maalox Nighttime Antacid Tablets Due to Illegible Labeling
FDA (Drugs) · 2013-08-28
- ModerateSolgar Glucosamine Chondroitin Recalled Due to Wrong Product Packaging Error
FDA (Food) · 2024-02-07
- ModerateHealthmaxx Recalls MAX Brand Glucosamine Tablets Due to Mislabeling
FDA (Food) · 2013-10-02